https://www.prnewswire.co.uk/news-releases/cyxone-makes-further-strides-with-rabeximod-phase-iib-trial-by-signing-cro-egeen-inc--899320004.html
Cyxone Makes Further Strides With Rabeximod Phase IIb Trial by Signing CRO EGeen Inc.
/PRNewswire/ -- Cyxone (publ), a Swedish biotech in autoimmune diseases, today announced that the company has signed an agreement with EGeen Inc., a clinical...